According to authorities in China, a drug used in Japan to treat new strains of influenza has appeared to be effective in coronavirus patients.
An official at China’s science and technology ministry, said favipiravir, developed by a subsidiary of Fujifilm, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients.
Patients who were given the medicine turned negative for the virus after an average of four days after becoming positive, compared with an average of 11 days for those who were not treated with the drug.
In addition, X-rays confirmed improvements in lung condition in about 91% of the patients who were treated with favipiravir, compared to 62% or those without the drug.
French government spokesperson Gabriel Attal has said that the newly announced inflation allowance will also be paid to "scholarship students and fisc...
Read More
According to a survey published today and carried out by Odoxa consulting 62% of French people today believe that the health pass is ultimately a "go...
Read More
Speaking on French television on Thursday evening Prime Minister Jean Castex has promised a "compensation of 100 euros for those who earn less than 2,...
Read More
Northern areas of France are gradually getting back to normal after the storm which affected the area last night and early this morning. Gusts of 175 ...
Read More
The man who was on the run suspected of having beheaded his grandfather has been arrested in the Bollène district in the Vaucluse. ...
Read More
